These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 28360411)
1. Interplay of DNA methyltransferase 1 and EZH2 through inactivation of Stat3 contributes to β-elemene-inhibited growth of nasopharyngeal carcinoma cells. Wu J; Tang Q; Yang L; Chen Y; Zheng F; Hann SS Sci Rep; 2017 Mar; 7(1):509. PubMed ID: 28360411 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of EZH2 via activation of SAPK/JNK and reduction of p65 and DNMT1 as a novel mechanism in inhibition of human lung cancer cells by polyphyllin I. Li L; Wu J; Zheng F; Tang Q; Wu W; Hann SS J Exp Clin Cancer Res; 2016 Jul; 35(1):112. PubMed ID: 27421653 [TBL] [Abstract][Full Text] [Related]
3. β-elemene inhibited expression of DNA methyltransferase 1 through activation of ERK1/2 and AMPKα signalling pathways in human lung cancer cells: the role of Sp1. Zhao S; Wu J; Zheng F; Tang Q; Yang L; Li L; Wu W; Hann SS J Cell Mol Med; 2015 Mar; 19(3):630-41. PubMed ID: 25598321 [TBL] [Abstract][Full Text] [Related]
4. HOTAIR-mediated reciprocal regulation of EZH2 and DNMT1 contribute to polyphyllin I-inhibited growth of castration-resistant prostate cancer cells in vitro and in vivo. Xiang S; Zou P; Tang Q; Zheng F; Wu J; Chen Z; Hann SS Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):589-599. PubMed ID: 29221985 [TBL] [Abstract][Full Text] [Related]
5. Repression of PDK1- and LncRNA HOTAIR-Mediated EZH2 Gene Expression Contributes to the Enhancement of Atractylenolide 1 and Erlotinib in the Inhibition of Human Lung Cancer Cells. Xiao Q; Zheng F; Tang Q; Wu JJ; Xie J; Huang HD; Yang XB; Hann SS Cell Physiol Biochem; 2018; 49(4):1615-1632. PubMed ID: 30223276 [TBL] [Abstract][Full Text] [Related]
6. Inactivation of Stat3 and crosstalk of miRNA155-5p and FOXO3a contribute to the induction of IGFBP1 expression by beta-elemene in human lung cancer. Zheng F; Tang Q; Zheng XH; Wu J; Huang H; Zhang H; Hann SS Exp Mol Med; 2018 Sep; 50(9):1-14. PubMed ID: 30209296 [TBL] [Abstract][Full Text] [Related]
7. Activation of ERK and Mutual Regulation of Stat3 and SP1 Contribute to Inhibition of PDK1 Expression by Atractylenolide-1 in Human Lung Cancer Cells. Xiao Q; Zheng F; Wu J; Tang Q; Wang W; Hann SS Cell Physiol Biochem; 2017; 43(6):2353-2366. PubMed ID: 29073620 [TBL] [Abstract][Full Text] [Related]
8. Crucifera sulforaphane (SFN) inhibits the growth of nasopharyngeal carcinoma through DNA methyltransferase 1 (DNMT1)/Wnt inhibitory factor 1 (WIF1) axis. Chen L; Chan LS; Lung HL; Yip TTC; Ngan RKC; Wong JWC; Lo KW; Ng WT; Lee AWM; Tsao GSW; Lung ML; Mak NK Phytomedicine; 2019 Oct; 63():153058. PubMed ID: 31394414 [TBL] [Abstract][Full Text] [Related]
9. EZH2 suppresses the nucleotide excision repair in nasopharyngeal carcinoma by silencing XPA gene. Huang Y; Wang X; Niu X; Wang X; Jiang R; Xu T; Liu Y; Liang L; Ou X; Xing X; Li W; Hu C Mol Carcinog; 2017 Feb; 56(2):447-463. PubMed ID: 27253463 [TBL] [Abstract][Full Text] [Related]
10. EZH2-DNMT1-mediated epigenetic silencing of miR-142-3p promotes metastasis through targeting ZEB2 in nasopharyngeal carcinoma. Li Y; He Q; Wen X; Hong X; Yang X; Tang X; Zhang P; Lei Y; Sun Y; Zhang J; Wang Y; Ma J; Liu N Cell Death Differ; 2019 Jun; 26(6):1089-1106. PubMed ID: 30353102 [TBL] [Abstract][Full Text] [Related]
11. Targeting EP4 downstream c-Jun through ERK1/2-mediated reduction of DNMT1 reveals novel mechanism of solamargine-inhibited growth of lung cancer cells. Chen Y; Tang Q; Xiao Q; Yang L; Hann SS J Cell Mol Med; 2017 Feb; 21(2):222-233. PubMed ID: 27620163 [TBL] [Abstract][Full Text] [Related]
13. Berberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts. Tsang CM; Cheung YC; Lui VW; Yip YL; Zhang G; Lin VW; Cheung KC; Feng Y; Tsao SW BMC Cancer; 2013 Dec; 13():619. PubMed ID: 24380387 [TBL] [Abstract][Full Text] [Related]
14. Activation of SAPK/JNK mediated the inhibition and reciprocal interaction of DNA methyltransferase 1 and EZH2 by ursolic acid in human lung cancer cells. Wu J; Zhao S; Tang Q; Zheng F; Chen Y; Yang L; Yang X; Li L; Wu W; Hann SS J Exp Clin Cancer Res; 2015 Sep; 34(1):99. PubMed ID: 26362062 [TBL] [Abstract][Full Text] [Related]
15. Enhancer of zeste homolog 2 overexpression in nasopharyngeal carcinoma: an independent poor prognosticator that enhances cell growth. Hwang CF; Huang HY; Chen CH; Chien CY; Hsu YC; Li CF; Fang FM Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):597-604. PubMed ID: 21300475 [TBL] [Abstract][Full Text] [Related]
16. Celecoxib induces apoptosis and cell-cycle arrest in nasopharyngeal carcinoma cell lines via inhibition of STAT3 phosphorylation. Liu DB; Hu GY; Long GX; Qiu H; Mei Q; Hu GQ Acta Pharmacol Sin; 2012 May; 33(5):682-90. PubMed ID: 22504904 [TBL] [Abstract][Full Text] [Related]
17. Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis. Zhao M; Hu X; Xu Y; Wu C; Chen J; Ren Y; Kong L; Sun S; Zhang L; Jin R; Zhou X Int J Oncol; 2019 Nov; 55(5):1165-1175. PubMed ID: 31545422 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA H19 regulates EZH2 expression by interacting with miR-630 and promotes cell invasion in nasopharyngeal carcinoma. Li X; Lin Y; Yang X; Wu X; He X Biochem Biophys Res Commun; 2016 May; 473(4):913-919. PubMed ID: 27040767 [TBL] [Abstract][Full Text] [Related]
19. [Effects of enhancer of zeste homolog (EZH2) downregulation on the proliferation and invasion of nasopharyngeal carcinoma cell and the possible mechanisms]. LIANG BJ; LI XP; LU J; LIN SX; LIU X; LI G; ZHANG B; WANG L; LUO HN; WAN RQ; TIAN WD Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 47(4):298-304. PubMed ID: 22800347 [TBL] [Abstract][Full Text] [Related]
20. EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells. Zheng M; Cao MX; Luo XJ; Li L; Wang K; Wang SS; Wang HF; Tang YJ; Tang YL; Liang XH J Cell Mol Med; 2019 Oct; 23(10):6942-6954. PubMed ID: 31368152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]